Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-22

Clinical Trial Update: Treatment Planning for ABA Employing Auxiliary Tools V2+ (TREAAT2+) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 1/2 study of TREAAT2+ for autism spectrum disorder using ABA with auxiliary tools; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Montera Health Texas LLC | Conditions: Autism Spectrum Disorder | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING